{"entity":{"type":"insider","cik":"0001871002","url":"/insider/0001871002","json_url":"/insider/0001871002.json","name":"Gassert Chad","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":13,"first":"2022-03-22","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Gassert Chad","source":"filing","n_filings":13,"first_seen":"2022-03-22","last_seen":"2025-11-14"}],"transactions":[{"id":4254030,"accession":"0001871002-25-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001871002-25-000007","line_url":"/filing/0001871002-25-000007#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94.0,"shares_display":"94","price_per_share":88.0,"price_display":"88.00","price_state":"stated","total_value":8272.0,"total_display":"8,272.00","shares_owned_after":158490.0,"shares_owned_after_display":"158,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-11-14","scope":"insider"},{"id":4254026,"accession":"0001871002-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-25-000007","line_url":"/filing/0001871002-25-000007#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14642.0,"shares_display":"14,642","price_per_share":89.07,"price_display":"89.07","price_state":"stated","total_value":1304162.94,"total_display":"1,304,162.94","shares_owned_after":158584.0,"shares_owned_after_display":"158,584","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4826394,"accession":"0001871002-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-25-000004","line_url":"/filing/0001871002-25-000004#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":86.97,"price_display":"86.97","price_state":"stated","total_value":1739400.0,"total_display":"1,739,400.00","shares_owned_after":173226.0,"shares_owned_after_display":"173,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-18","scope":"insider"},{"id":2446052,"accession":"0001871002-24-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-24-000014","line_url":"/filing/0001871002-24-000014#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":63.44,"price_display":"63.44","price_state":"stated","total_value":1268800.0,"total_display":"1,268,800.00","shares_owned_after":193226.0,"shares_owned_after_display":"193,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":2926727,"accession":"0001871002-24-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-24-000012","line_url":"/filing/0001871002-24-000012#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":64.41,"price_display":"64.41","price_state":"stated","total_value":1288200.0,"total_display":"1,288,200.00","shares_owned_after":213226.0,"shares_owned_after_display":"213,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-03","filed_date":"2024-06-04","scope":"insider"},{"id":2574288,"accession":"0001871002-24-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-24-000010","line_url":"/filing/0001871002-24-000010#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":66.62,"price_display":"66.62","price_state":"stated","total_value":1332400.0,"total_display":"1,332,400.00","shares_owned_after":233226.0,"shares_owned_after_display":"233,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":2811224,"accession":"0001871002-24-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-24-000008","line_url":"/filing/0001871002-24-000008#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":67.25,"price_display":"67.25","price_state":"stated","total_value":1345000.0,"total_display":"1,345,000.00","shares_owned_after":253226.0,"shares_owned_after_display":"253,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-02","scope":"insider"},{"id":3273869,"accession":"0001871002-24-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-24-000006","line_url":"/filing/0001871002-24-000006#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":65.81,"price_display":"65.81","price_state":"stated","total_value":1316200.0,"total_display":"1,316,200.00","shares_owned_after":273226.0,"shares_owned_after_display":"273,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider"},{"id":8050645,"accession":"0001871002-23-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-23-000009","line_url":"/filing/0001871002-23-000009#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":56.48,"price_display":"56.48","price_state":"stated","total_value":1129600.0,"total_display":"1,129,600.00","shares_owned_after":293226.0,"shares_owned_after_display":"293,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-02","filed_date":"2023-10-03","scope":"insider"},{"id":8553562,"accession":"0001871002-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-23-000006","line_url":"/filing/0001871002-23-000006#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":64.7,"price_display":"64.70","price_state":"stated","total_value":1294000.0,"total_display":"1,294,000.00","shares_owned_after":313226.0,"shares_owned_after_display":"313,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8490890,"accession":"0001871002-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001871002-23-000004","line_url":"/filing/0001871002-23-000004#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.06,"price_display":"51.06","price_state":"stated","total_value":1021200.0,"total_display":"1,021,200.00","shares_owned_after":333226.0,"shares_owned_after_display":"333,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-03","scope":"insider"},{"id":8357457,"accession":"0001104659-23-078742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078742","line_url":"/filing/0001104659-23-078742#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":53.43,"price_display":"53.43","price_state":"stated","total_value":1068600.0,"total_display":"1,068,600.00","shares_owned_after":353226.0,"shares_owned_after_display":"353,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":7860602,"accession":"0001104659-23-074398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-074398","line_url":"/filing/0001104659-23-074398#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":51.32,"price_display":"51.32","price_state":"stated","total_value":1026400.0,"total_display":"1,026,400.00","shares_owned_after":373226.0,"shares_owned_after_display":"373,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-22","filed_date":"2023-06-23","scope":"insider"},{"id":6904713,"accession":"0001415889-22-003267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-003267","line_url":"/filing/0001415889-22-003267#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":27.8685,"price_display":"27.87","price_state":"stated","total_value":139342.5,"total_display":"139,342.50","shares_owned_after":393226.0,"shares_owned_after_display":"393,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-22","scope":"insider"},{"id":6904708,"accession":"0001415889-22-003267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-003267","line_url":"/filing/0001415889-22-003267#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001871002","owner_name":"Gassert Chad","owner_url":"/insider/0001871002","role":"Officer (SVP - CORP. DEV. & STRATEGY)","officer_title":"SVP - CORP. DEV. & STRATEGY","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":27.1488,"price_display":"27.15","price_state":"stated","total_value":135744.0,"total_display":"135,744.00","shares_owned_after":388226.0,"shares_owned_after_display":"388,226","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023024","name":"ANI PHARMACEUTICALS INC","url":"/issuer/0001023024","role":"Officer (SVP - CORP. DEV. & STRATEGY)","n_filings":13,"first_seen":"2022-03-22","last_seen":"2025-11-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001871002","retrieved_at":"2026-08-21T14:59:21+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}